Pirfenidone 8% Gel in Dermatology

1. Drug class

• Topical antifibrotic drug
• Pirfenidone is a synthetic pyridone compound with antifibrotic, anti-inflammatory, and antioxidant actions.
• Oral pirfenidone is used for idiopathic pulmonary fibrosis. The 8% gel formulation has been studied for cutaneous fibrosis and scar disorders.

2. Mechanism of action

• Inhibiting TGF-beta, a key profibrotic cytokine
• Reducing fibroblast proliferation and collagen synthesis
• Decreasing extracellular-matrix deposition
• Suppressing inflammatory cytokines, including TNF-alpha and IL-1 beta
• Increasing anti-inflammatory IL-10 activity

3. Dermatological indications

1. Hypertrophic burn scars
2. Keloids - studied and used as an adjunct or investigational topical option
3. Localized scleroderma (morphea), particularly active localized plaques
4. Other fibrosing disorders are theoretical or investigational indications.

4. Formulation and application

• Strength: Pirfenidone 8% topical gel
• Apply a thin layer over the involved scar or plaque.
• Common study regimen: three times daily for 6 months.
• In the morphea phase-II study, one fingertip unit, about 0.5 g, was used for approximately 100-120 cm² of skin.
• Apply only as advised by the treating dermatologist, usually to intact skin after cleaning and drying.

5. Evidence in dermatology

A. Hypertrophic burn scars

B. Localized scleroderma / morphea

• Improvement in modified Localized Scleroderma Skin Severity Index
• Reduction in plaque induration
• Histological improvement in inflammation and fibrosis

6. Adverse effects and precautions

• Transient burning or stinging at application site
• Local irritation, erythema, dryness, or pruritus
• Potential photosensitivity or phototoxic reaction

• Use sunscreen and protective clothing.
• Avoid excessive sun exposure.
• Stop and seek review if significant dermatitis, blistering, or severe burning occurs.
• Avoid eyes, mucosa, and open wounds unless specifically directed.
• Pregnancy and lactation safety data for topical use are insufficient, so specialist advice is needed.

7. Advantages

• Direct local delivery to diseased skin
• Low expected systemic exposure
• Noninvasive
• May target both inflammation and fibrosis
• Potentially useful where scar thickness, induration, and collagen excess predominate

8. Limitations

• Limited high-quality randomized evidence
• Few participants in available morphea studies
• Not universally available
• No firm consensus that it replaces established therapies such as silicone-based treatment, pressure therapy, intralesional corticosteroids for selected scars, phototherapy, or systemic treatment for significant active morphea.

Viva points

• What is pirfenidone? An antifibrotic and anti-inflammatory agent.
• What is the topical concentration used in dermatology? 8% gel.
• Main mechanism? Inhibition of TGF-beta mediated fibroblast activation and collagen deposition.
• Important dermatology uses? Hypertrophic scars, keloids, and localized scleroderma.
• Usual studied regimen? Thin topical application three times daily for about 6 months.
• Common adverse effect? Mild transient local burning/irritation.
• Important precaution? Photoprotection due to potential photosensitivity.
• Status in practice? A promising adjunct or selective option, not universally first-line because evidence and availability remain limited.

Azelaic Acid Gel in Dermatology

1. Drug class and preparation

• Topical dicarboxylic acid
• Has antimicrobial, anti-inflammatory, keratolytic/comedolytic, and depigmenting effects.
• Common preparations:
  • 15% gel: prescription formulation, commonly used for rosacea and acne
  • 20% cream: acne and pigmentary disorders
  • 10-14%: over-the-counter cosmetic formulations

2. Mechanism of action

3. Indications in dermatology

A. Acne vulgaris

• Mild to moderate comedonal and inflammatory acne
• Particularly useful when a patient has both acne and post-inflammatory hyperpigmentation (PIH)
• May be combined with benzoyl peroxide, a topical retinoid, oral antibiotics, or hormonal treatment when indicated.
• Does not cause antimicrobial resistance, unlike topical antibiotics.

B. Papulopustular rosacea

• 15% gel is commonly used for inflammatory papules and pustules of mild to moderate rosacea.
• It may also improve background erythema, though it is not primarily a treatment for persistent fixed erythema or telangiectasia.

C. Melasma and hyperpigmentation

• Melasma
• Post-inflammatory hyperpigmentation, especially acne-associated PIH
• Useful in darker skin types because it affects hyperactive melanocytes relatively selectively and has a low risk of inducing PIH compared with irritating treatments.

D. Other possible uses

• Perioral dermatitis and some follicular disorders have been treated off-label, but evidence is less established.

4. Dose and application

• Apply a thin layer to the entire affected area, not only individual lesions.
• Usually applied twice daily, morning and evening, after gentle cleansing and drying.
• In sensitive skin, begin once daily for 1-2 weeks and increase to twice daily if tolerated.
• Avoid eyes, lips, mucosa, and broken or eczematous skin.
• Use a non-comedogenic moisturizer if dryness occurs.
• Daily sunscreen is advised, especially for melasma and PIH.

5. Expected response

• Acne: initial improvement in about 4 weeks; maximum benefit may take several months.
• Rosacea: improvement may take up to 12 weeks.
• Melasma/PIH: gradual improvement over several weeks to months. Strict photoprotection is essential.

6. Adverse effects

• Burning or stinging
• Pruritus
• Erythema
• Dryness
• Peeling/scaling
• Irritant contact dermatitis

• Hypopigmentation may be noticeable in darker skin tones.
• Worsening asthma has been reported rarely. Ask patients with asthma to report worsening respiratory symptoms.
• Severe burning, edema, marked erythema, or persistent dermatitis warrants stopping the product and reviewing treatment.

7. Advantages

• Effective for both inflammatory and comedonal acne
• Useful when acne coexists with PIH or melasma
• No bacterial resistance
• Suitable for long-term use
• Generally well tolerated
• Considered acceptable in pregnancy in dermatology references, unlike topical retinoids. Use should still be individualized by the treating clinician.

8. Limitations

• Results are gradual
• Local irritation may limit adherence
• Less useful as sole therapy in severe nodulocystic acne
• Does not directly treat rosacea telangiectasia
• Sunscreen is mandatory for optimal pigmentary results

Practical viva points

• Drug class: Topical dicarboxylic acid.
• Usual gel concentration: 15%.
• Main uses: Acne vulgaris, papulopustular rosacea, melasma, and PIH.
• Antiacne mechanisms: Anti-C. acnes, anti-inflammatory, and normalizes follicular keratinization.
• Depigmenting mechanism: Tyrosinase inhibition and selective action on abnormal/hyperactive melanocytes.
• Usual frequency: Twice daily.
• Common adverse effect: Mild transient burning, dryness, peeling, or erythema.
• Key advantage over topical antibiotics: It does not induce bacterial resistance.
• Good clinical choice: Acne with post-inflammatory hyperpigmentation, particularly in skin of color.

Likely Practical Viva Questions on Azelaic Acid Gel

A. Identification and basics

1. What is azelaic acid?
   A naturally occurring saturated dicarboxylic acid with antimicrobial, anti-inflammatory, comedolytic, and depigmenting actions.
2. What are the usual strengths and formulations?
   • 15% gel or foam
   • 20% cream
   • 10-14% lower-strength cosmetic/OTC preparations
3. What is the usual frequency of application?
   Usually a thin layer twice daily. In sensitive skin, start once daily and increase if tolerated.
4. What is the standard gel strength used for rosacea?
   15% gel.
5. What are its principal dermatological indications?
   Acne vulgaris, papulopustular rosacea, melasma, and post-inflammatory hyperpigmentation.

B. Mechanism-based questions

1. How does azelaic acid improve acne?
   It:
   • Inhibits Cutibacterium acnes
   • Normalizes abnormal follicular keratinization, giving a comedolytic effect
   • Reduces inflammation and neutrophil-derived reactive oxygen species
2. Is azelaic acid a topical antibiotic?
   No. It has antimicrobial action but is not classified as a conventional topical antibiotic.
3. Why is it useful in acne in the era of antibiotic stewardship?
   It does not promote bacterial antibiotic resistance, unlike prolonged topical antibiotic monotherapy.
4. How does it improve hyperpigmentation?
   It inhibits tyrosinase and selectively reduces activity of hyperactive or abnormal melanocytes, with relatively little effect on normal melanocytes.
5. Why does it help inflammatory dermatoses such as rosacea?
   It reduces neutrophil-mediated oxidative injury and has anti-inflammatory effects.
6. Does azelaic acid reduce sebum production?
   No. It is not primarily sebosuppressive.

C. Acne questions

1. Which type of acne responds to azelaic acid?
   Both comedonal and mild to moderate inflammatory acne.
2. Can it be used as monotherapy in acne?
   Yes, in mild acne. In moderate disease it is often combined with other agents according to lesion type and severity.
3. Where would you place it in acne management?
   It is a useful alternative or adjunct topical agent, especially where acne coexists with PIH, sensitive skin, intolerance to retinoids, or need to avoid topical antibiotics.
4. What makes azelaic acid particularly useful in skin of color?
   It treats acne while also helping acne-related PIH, which is frequent and may be more distressing than active lesions.
5. Can it replace isotretinoin in nodulocystic acne?
   No. It is not adequate as sole therapy for severe nodulocystic acne or acne causing scarring.
6. Can azelaic acid be combined with a topical retinoid?
   Yes, but start carefully because the combination may increase irritation. Introduce one treatment at a time or use them at different times of day.
7. Can it be combined with benzoyl peroxide?
   Yes, but dryness and irritation may be additive. Use a gentle cleanser and moisturizer.
8. How does it compare with topical antibiotics?
   It has no concern of antibiotic resistance and also benefits PIH. However, topical antibiotics may have a role in inflammatory acne when appropriately combined with benzoyl peroxide.
9. What is the current guideline position in acne?
   The 2024 American Academy of Dermatology guideline gives a conditional recommendation for azelaic acid in acne. Stronger recommendations exist for benzoyl peroxide, topical retinoids, and selected topical antibiotics. See the 2024 acne guideline.

D. Rosacea questions

1. In which subtype of rosacea is azelaic acid useful?
   Mainly papulopustular rosacea.
2. Does it treat telangiectasia?
   No. Telangiectasia usually requires vascular laser or intense pulsed light, depending on the case.
3. Does it treat persistent facial erythema?
   It may improve inflammatory erythema to some extent, but topical vasoconstrictors such as brimonidine or oxymetazoline are more specifically used for persistent erythema.
4. What is the common regimen in papulopustular rosacea?
   Azelaic acid 15% gel, applied twice daily.
5. How long should a patient use it before assessing response in rosacea?
   Usually around 8-12 weeks.
6. What advice do you give a rosacea patient using azelaic acid?
   Gentle skin care, avoid known triggers, use sunscreen, avoid abrasive scrubs and alcohol-containing astringents, and introduce treatment gradually if sensitive.

E. Melasma and PIH questions

1. What is the role of azelaic acid in melasma?
   It is a non-hydroquinone depigmenting option, generally used at 15-20%, often as an adjunct to strict photoprotection.
2. How does it compare with hydroquinone?
   Hydroquinone remains a commonly used potent depigmenting agent. Azelaic acid is generally better tolerated and useful for longer-term treatment or when hydroquinone is unsuitable, but response may be gradual.
3. Can azelaic acid be used alone for melasma?
   It can be, but sunscreen is non-negotiable. Combination therapy may be required in resistant melasma.
4. What is the most important co-treatment in melasma?
   Broad-spectrum, preferably tinted sunscreen with visible-light protection, plus avoidance of excessive sun and heat exposure.
5. Why is it useful in post-acne pigmentation?
   It simultaneously treats active acne and hyperpigmentation, reducing the need for multiple irritating agents.

F. Safety and counseling questions

1. What are the common adverse effects?
   Burning, stinging, pruritus, erythema, dryness, scaling, and peeling.
2. What type of dermatitis can it cause?
   Mild to moderate irritant contact dermatitis.
3. What will you do if there is mild irritation?
   Reduce frequency to once daily or alternate days, use moisturizer, avoid simultaneous irritating products, then increase gradually as tolerated.
4. When should the patient stop the drug?
   Severe burning, marked erythema, swelling, blistering, persistent dermatitis, or suspected allergy warrants stopping and reassessment.
5. Can it cause photosensitivity?
   It is not classically photosensitizing. Sunscreen remains important because its main pigmentary indications, especially melasma and PIH, worsen with ultraviolet and visible light.
6. Can it bleach clothes or normal skin like benzoyl peroxide?
   No. It does not bleach clothing.
7. Can it cause hypopigmentation?
   Uncommonly, localized hypopigmentation may occur and can be more conspicuous in darker skin tones.
8. What special caution is relevant in asthma?
   Rare reports of worsening asthma exist. Advise patients to report any respiratory worsening.
9. Can it be used in pregnancy?
   It is generally considered an acceptable topical option in pregnancy and is often preferred when acne treatment is needed, but treatment should still be individualized.
   Avoid saying “completely safe” in a viva. Say: “generally considered acceptable/low risk when clinically indicated.”
10. What about breastfeeding?
    Systemic absorption is low, but avoid application on the nipple or any area likely to contact the infant’s mouth.

G. Practical prescription and counseling station questions

1. How would you prescribe it for acne with PIH?
   “Azelaic acid 15% gel, apply a pea-sized amount as a thin layer over the acne-prone affected area once nightly for 1-2 weeks, then twice daily if tolerated. Use moisturizer and broad-spectrum sunscreen daily.”
2. Why apply to the entire acne-prone area rather than only lesions?
   It prevents new microcomedones and treats subclinical disease, not merely visible lesions.
3. What should be avoided at the same time initially?
   Harsh cleansers, scrubs, astringents, peeling agents, and simultaneous overuse of retinoids, benzoyl peroxide, or exfoliating acids.
4. How would you improve adherence?
   Explain that temporary stinging may occur, start slowly, use a moisturizer, set realistic timelines, and instruct regular application.
5. When do you review?
   Around 6-12 weeks, earlier if severe irritation occurs.

H. Comparison questions

I. Recent-advance questions an examiner may use

1. Why is azelaic acid receiving renewed interest?
   It addresses several common problems simultaneously: inflammatory acne, comedones, acne-related PIH, rosacea inflammation, and pigmentary disorders, while avoiding antibiotic resistance.
2. What formulation research is ongoing?
   New vehicles such as liposomes, niosomes, microemulsions, nanostructured lipid carriers, and other delivery systems are being investigated to improve skin penetration, stability, and tolerability. These are promising but not yet routine standard care.
3. Are OTC 10% products equivalent to prescription 15-20% preparations?
   No. OTC products can be useful for some patients, but formulation, vehicle, stability, actual concentration, and clinical evidence differ. Prescription formulations have stronger evidence for acne and rosacea.
4. What is the highest-yield modern role of azelaic acid?
   Acne with PIH, especially in patients with sensitive skin or skin of color, and papulopustular rosacea.
5. Is evidence equally strong for all claimed cosmetic uses, such as anti-aging?
   No. Evidence is much stronger for acne, rosacea, melasma, and PIH than for “anti-aging” claims. A 2023 systematic review evaluated acne, rosacea, melasma, and skin aging but evidence varies between conditions. See the systematic review.

Ten one-line answers to memorize

1. Azelaic acid is a topical dicarboxylic acid.
2. 15% gel is commonly used for papulopustular rosacea.
3. It is antimicrobial, anti-inflammatory, comedolytic, and depigmenting.
4. It acts against Cutibacterium acnes without inducing antibiotic resistance.
5. It normalizes follicular keratinization.
6. It inhibits tyrosinase, so it improves melasma and PIH.
7. It is especially useful in acne associated with PIH.
8. The usual schedule is a thin layer twice daily.
9. Common adverse effects are burning, dryness, erythema, and peeling.
10. It is generally considered an acceptable topical option during pregnancy when needed.